OrthoSpin

Developer of a smart external fixation system for bone injuries, bone lengthening, and limb deformities.

Health Tech & Life Sciences
Acquired by DePuy Synthes
Acquired Yokne'am Illit, Israel Founded 2014
Last updated 2026-07-23
Total raised
$8.0M
Last: Undisclosed Round 2020-03
Stage
Acquired
Founded
2014
Headcount
3
HQ
Yokne'am Illit, Israel
Sector
Health Tech & Life Sciences

About

OrthoSpin developed a robotic, digitally-enabled external fixation system for orthopedic treatments. The system uses a strut powered by a lightweight motor and a control box on a circular hexapod fixation frame to automatically and continuously adjust and lengthen struts according to a prescribed treatment regimen, without patient involvement. The company also developed proprietary software that allows physicians to chart patient progress and modify treatment schedules. OrthoSpin's system aims to improve patient compliance and provide real-time data for physician follow-up during the lengthy rehabilitation period associated with external fixation devices.

Funding history · 3 rounds · $8.0M total

2020-02
B Round $5.0M
★ Johnson & Johnson Innovation
2018-06
A Round $3.0M
★ Johnson & Johnson Innovation
2015-11
Seed Undisclosed

Headcount over time

From 4 (2019-04) to 8 (2026-07) · +4 (+100%) · 13 points · source: Finder history + radar grounding
80 2019-04 2026-07

Q&A

What is OrthoSpin's primary business?
OrthoSpin develops a smart external fixation system that uses robotics to automatically adjust and lengthen struts for orthopedic treatment, allowing real-time physician follow-up and reducing patient compliance dependence.
When was OrthoSpin acquired and by whom?
OrthoSpin was acquired by DePuy Synthes in November 2021.
What was OrthoSpin's total funding raised before its acquisition?
OrthoSpin raised a total of $8 million in funding.
Which investors participated in OrthoSpin's March 2020 funding round?
The March 2020 funding round included investment from Johnson & Johnson Innovation.
When did OrthoSpin receive FDA clearance for its second-generation system?
In January 2021, OrthoSpin received regulatory clearance from the FDA for its second-generation robotic, digitally enabled external fixation system for orthopedic treatments.
What is the status of OrthoSpin's G2 system?
The OrthoSpin G2 system is approved in Israel, cleared for use in the United States, and can be used with the DePuy Synthes MAXFRAME Multi-Axial Correction System.
When was OrthoSpin founded?
OrthoSpin was founded in December 2014.

Team · 1

Ofer Vikinsky
Founder · Co-Founder & CTO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Therapeutics
Technologies
Machinery & Robotics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Tags

medical-devicessurgeryorthopedicsroboticsdoctorsreal-timesaasautomationdigital-healthcaredigital-therapeutics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteorthospin.com
LinkedInlinkedin.com/company/29001774

Identifiers & details

Legal nameOrthoSpin Ltd.
Founded2014-12
Employees (exact)3
Status reasonAcquired by DePuy Synthes on Nov, 2021

Acquisitions & public offerings

Acquired by DePuy Synthes 2021-11 $79.5M

Radar intelligence

Patents

EPO3

Web history (Wayback)

Domainorthospin.com

Certificate / subdomain footprint

Subdomains8

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515158608
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2014-11-24
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2024
Active charges / liens0
Registry events0
Registered addressהיצירה 13 יקנעם עילית